XML 27 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-based compensation
6 Months Ended
Jun. 30, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Share-based compensation

10. Share-based compensation

The following tables present the detail of share-based compensation by line item in the condensed consolidated statements of income as well as by award type:

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

(U.S. Dollars, in thousands)

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Cost of sales

 

$

132

 

 

$

137

 

 

$

257

 

 

$

286

 

Sales and marketing

 

 

473

 

 

 

319

 

 

 

922

 

 

 

679

 

General and administrative

 

 

4,249

 

 

 

2,005

 

 

 

7,294

 

 

 

4,107

 

Research and development

 

 

361

 

 

 

215

 

 

 

658

 

 

 

420

 

 

 

$

5,215

 

 

$

2,676

 

 

$

9,131

 

 

$

5,492

 

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

(U.S. Dollars, in thousands)

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Stock options

 

$

1,241

 

 

$

523

 

 

$

1,863

 

 

$

1,118

 

Time-based restricted stock awards and units

 

 

1,789

 

 

 

1,239

 

 

 

3,236

 

 

 

2,531

 

Performance-based restricted stock awards

 

 

270

 

 

 

113

 

 

 

759

 

 

 

225

 

Performance-based and market-based restricted stock units

 

 

1,604

 

 

 

472

 

 

 

2,557

 

 

 

938

 

Stock purchase plan

 

 

311

 

 

 

329

 

 

 

716

 

 

 

680

 

 

 

$

5,215

 

 

$

2,676

 

 

$

9,131

 

 

$

5,492

 

During the three months ended June 30, 2018 and 2017, the Company issued 80,444 and 76,596 shares, respectively, of common stock related to stock purchase plan issuances, stock option exercises and the vesting of restricted stock awards. During the six months ended June 30, 2018 and 2017, the Company issued 206,955 and 291,275 shares, respectively, of common stock related to stock purchase plan issuances, stock option exercises and the vesting of restricted stock awards.